Diabetes and slimming drug Mounjaro: more weight loss than Ozempic

Diabetes and slimming drug Mounjaro: more weight loss than Ozempic
– how to remain healthy, health and wellbeing, latest symptoms and treatments.

Diabetes and slimming drug Mounjaro: more weight loss than Ozempic

Just like Ozempic, Mounjaro is a drug against type 2 diabetes that extends the digestive time and suppresses the hunger feeling, leading to weight loss. As a result, the resources also arouse interest in people who have obesity. With Mounjaro you would lose 20 percent of your body weight, while at Ozempic that is an average of 10 percent.

Also read: Is Ozempic diabetes drug a panacea to lose weight quickly?

Table of Contents

Mounjaro: For whom?

Mounjaro is intended for adults with type 2 diabetes and/or for people with a BMI of 30 and more. Also with a BMI of 27 and more you are eligible if you have at least 1 underlying condition that is linked to weight loss, such as cardiovascular disease, pre-diabetes and sleep apnea.

YOU MAY HAVE MISSED:

Importance of the pelvic floor: 'Half of pregnant women suffer from urinary incontinence'

Also read: Which sports can you lose belly fat with?

How does Mounjaro work?

Mounjaro, also known as the generic name Tirzepatide, has been accelerated by the American Food and Drink Administration (FDA) for the treatment of obesity, after a study had shown that it helped people to lose more than 20% of their body weight. Just like Ozempic – the brand name for Semaglutide – you have to inject Mounjaro once a week.

Both Semaglutide and Tirzepatide work by simulating the hormone GLP-1 (glucagon-like peptide one) to control the feeling of hunger and delaying digestion. However, Tirzepatide is a double-acting medicine and also mimics the hormone plaster, glucose-dependent insulinotropic polypeptide. This ensures that Mounjaro achieves even better results than Ozempic. In fact, it is so effective that it brings the blood sugar values of some diabetic patients within the normal limits. Participants of clinical tests lost 20 percent and 15 percent of their body weight respectively. During these tests, higher doses of Mounjaro were administered than those who are now on the market in Belgium.

The medicines work as long as you take them. As soon as you stop, it also stops. Anyone who takes Mounjaro with a view to weight loss, is therefore better to adjust their lifestyle, otherwise the lost weight will be added.

YOU MAY HAVE MISSED:

Discover the impact of 'A Week Healthier' for yourself

Read also: Medicine against obesity saxenda: limited effect and risk of side effects

Side effects of Mounjaro

Mounjaro is not recommended for people who occur in the medullary thyroid carcinoma in the family, a specific type of thyroid cancer. The same applies to those who have multiple endocrine neoplasia type 2, a condition of the endocrine system. Anyone who uses Mounjaro and suffers from a lump or swelling in the neck, problems with swallowing, hoarseness or shortness of breath, need to consult medical help urgently.

Also read: Do you have to worry about a tumor or lump in the neck?

Mounjaro in Belgium: cost price

Mounjaro is now also available on prescription in Belgium. The price of an injection of four doses Mounjaro is 232.8 euros, which is sufficient for one month of treatment. Mounjaro is currently not being repaid in Belgium. However, a reimbursement procedure is running for patients with type 2 diabetes, the RIZIV reports. For people with obesity, there is no refund yet.

The higher doses are expected to be available on the Belgian market in 2025, but are probably also considerably more expensive.

Sources:

Last updated: November 2024